Ikena Oncology Inc.

NASDAQ: IKNA · Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM

Ikena Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
39.39M 119.89M 59.92M 232.22M
Short-Term Investments
84.99M 55.57M 97.03M n/a
Long-Term Investments
n/a n/a 872K 2.39M
Other Long-Term Assets
10.11M 5.41M 2.92M n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.78M 1.15M 964K 629K
Total Current Assets
127.17M 178.66M 160.01M 236.52M
Property-Plant & Equipment
4.23M 8.02M 8.46M 8.98M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
14.34M 13.43M 12.25M 11.36M
Total Assets
141.51M 192.09M 172.26M 247.88M
Account Payables
897K 2.07M 2.09M 2.38M
Deferred Revenue
n/a n/a 9.16M 17.1M
Short-Term Debt
3.78M n/a 1.91M 1.85M
Other Current Liabilities
6.1M 3.4M 3.2M 1.19M
Total Current Liabilities
10.78M 14.21M 21.5M 27.19M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.06M 950K n/a n/a
Total Long-Term Liabilities
4.8M 8.13M 3.79M 12.81M
Total Liabilities
15.58M 22.34M 25.29M 40M
Total Debt
7.52M 10.74M 5.69M 6.99M
Common Stock
48K 48K 36K 36K
Retained Earnings
-331.62M -282.38M -214.22M -145.45M
Comprehensive Income
68K -48K -763K -247.88M
Shareholders Equity
125.93M 169.76M 146.97M 207.88M
Total Investments
84.99M 55.57M 97.03M 2.39M